SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Vascular and Endovascular Surgery
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hardev Ramandeep Singh Girn
Right arrow Articles by Homer-Vanniasinkam, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hardev Ramandeep Singh Girn,
Right arrow Articles by Homer-Vanniasinkam, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reviews

Reperfusion Syndrome: Cellular Mechanisms of Microvascular Dysfunction and Potential Therapeutic Strategies

Hardev Ramandeep Singh Girn, MRCS

Leeds Vascular Institute, Leeds General Infirmary, Leeds, UK, hrsgirn{at}aol.com

Sashi Ahilathirunayagam, MBBS

Leeds Vascular Institute, Leeds General Infirmary, Leeds, UK

Andrew I. D. Mavor, FRCS

Leeds Vascular Institute, Leeds General Infirmary, Leeds, UK

Shervanthi Homer-Vanniasinkam, FRCS

Leeds Vascular Institute, Leeds General Infirmary, Leeds, UK

Reperfusion injury is the paradoxical and complex phenomenon of exacerbation of cellular dysfunction and increase in cell death after the restoration of blood flow to previously ischemic tissues. It involves biochemical and cellular changes causing oxidant production and complement activation, which culminates in an inflammatory response, mediated by neutrophil and platelet cell interactions with the endothelium and among the cells themselves. The mounted inflammatory response has both local and systemic manifestations. Despite improvements in imaging, interventional techniques, and pharmacological agents, morbidity from reperfusion remains high. Extensive research has furthered the understanding of the various pathophysiological mechanisms involved and the development of potential therapeutic strategies. Preconditioning has emerged as a powerful method of ameliorating ischemia reperfusion injury to the myocardium and in transplant surgery. More recently, postconditioning has been shown to provide a therapeutic counter to vasoocclusive emergencies. More research and well-designed trials are needed to bridge the gap between experimental evidence and clinical implementation.

Key Words: ischemia • reperfusion • endothelial dysfunction • microvascular dysfunction • nitric oxide • adhesion molecules • cytokines • preconditioning • postconditioning

References

  • Bywaters EG, Beall D. Crush injuries with impairment of renal function. Br Med J. 1941;1:427-432.[Free Full Text]
  • Hearse DJ Reperfusion of the ischaemic myocardium. J Mol Cell Cardiol. 1977; 9:605-616.[Web of Science][Medline] [Order article via Infotrieve]
  • Haimovici H. Arterial embolism with acute massive ischemic myopathy and myoglobinuria. Surgery. 1960; 47:739-747.[Web of Science][Medline] [Order article via Infotrieve]
  • Parks DA, Granger DN Contributions of ischaemia and reperfusion to mucosal lesion formation. Am J Physiol. 1986;250:749-753.
  • Reimer KA, Murry CE, Richard VJ The role of neutrophils and free radicals in the ischemia-reperfused heart: why the confusion and controversy? J Mol Cell Cardiol. 1989;21:1225-1239.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Neary P., Redmond HP Ischaemia-reperfusion injury and the systemic inflammatory response syndrome. In: Grace PA, Mathie RT, eds. Ischaemia-Reperfusion Injury. Oxford, UK: Blackwell Science; 1999: 123-136.
  • Davies MG, Hagen PO The vascular endothelium: a new horizon. Ann Surg. 1993;218:593-609.[Web of Science][Medline] [Order article via Infotrieve]
  • Cines DB, Pollak ES, Buck CA, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998;91:3527-3561.[Free Full Text]
  • Vallet B. Endothelial cell dysfunction and abnormal tissue perfusion. Crit Care Med. 2002;30(5 suppl):229-234.[CrossRef]
  • Yang L., Froio RM, Sciuto TE, et al. ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-{alpha}-activated vascular endothelium under flow. Blood. 2005;106:584-592.[Abstract/Free Full Text]
  • Muller WA Migration of leukocytes across endothelial junctions: some concepts and controversies. Microcirculation. 2001;8:181-193.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kvietys PR, Sandig M. Neutrophil diapedesis: paracellular or transcellular? News Physiol Sci. 2001;16:15-19.[Abstract/Free Full Text]
  • Gough MJ, Crinnion JN, Homer-Vanniasinkam S. Local consequences of reperfusion in skeletal muscle. In: Grace PA, Mathie RT, eds. Ischaemia-Reperfusion Injury. Oxford, UK: Blackwell Science; 1999:31-43.
  • Gao JX, Issekutz AC Mac-1 (CD11b/CD18) is the predominant beta 2 (CD 18) integrin mediating human neutrophil migration through synovial and dermal fibroblast barriers. Immunology. 1996;88:463-470.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tyagi S., Klickstein LB, Nicholson-Weller A. C5a-stimulated human neutrophils use a subset of beta2 integrins to support the adhesion-dependent phase of superoxide production. J Leukoc Biol. 2000;68:679-686.[Abstract/Free Full Text]
  • Montrucchio G., Alloatti G., Camussi G. Role of platelet-activating factor in cardiovascular pathophysiology. Physiol Rev. 2000;80:1669-1699.[Abstract/Free Full Text]
  • Bevilacqua MJ, Prober J., Mendrick DL, Cotran RS, Gimbrone MA Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci USA. 1987;84:9238-9242.[Abstract/Free Full Text]
  • Faxon DP, Gibbons RJ, Chronos NA, Gurbel PA, Sheehan F.; HALT-MI Investigators. The effect of blockade of the CD11/CD18 integrin receptor on infarct size in patients with acute myocardial infarction treated with direct angioplasty: the results of the HALT-MI study. J Am Coll Cardiol. 2002;40:1199-1204.[Abstract/Free Full Text]
  • Bauerle PA, Henkel T. Function and activation of NF{kappa}B in the immune system. Annu Rev Immunol. 1994;12: 141-179.[Web of Science][Medline] [Order article via Infotrieve]
  • Springer TA Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell. 1994;76:301-314.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Smith CW, Marlin SD, Rothlein R., Toman C., Anderson DC Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro. J Clin Invest. 1989;83:2008-2017.[Web of Science][Medline] [Order article via Infotrieve]
  • Tan P., Luscinskas FW, Homer-Vanniasinkam S. Cellular and molecular mechanisms of inflammation and thrombosis. Eur J Vasc Endovasc Surg. 1999;17:373-389.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kansas GS Selectins and their ligands: current concepts and controversies. Blood. 1996;88:3259-3287.[Free Full Text]
  • Tedder TF, Steeber DA, Chen A., Engel P. The selectins: vascular adhesion molecules. FASEB J. 1995;9:866-873.[Abstract]
  • Banga NR, Homer-Vanniasinkam S., Graham A., Al-Mukhtar A., White SA, Prasad KR Ischaemic preconditioning in transplantation and major resection of the liver. Br J Surg. 2005;92:528-538.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Yadav SS, Howell DN, Gao W., et al. L-selectin and ICAM-1 mediate reperfusion injury and neutrophil adhesion in the warm ischaemic mouse liver. Am J Physiol. 1998;275:1341-1352.
  • Singh I., Zibari GB, Zizzi H., et al. Anti-P-selectin antibody protects against hepatic ischemia-reperfusion injury. Transplant Proc. 1998;30:2324-2326.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jaeschke H., Farhood A., Gautista AP, Spolarics Z., Spitzer JJ, Smith CW Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology. 1993;17:915-923.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Nishimura Y., Takei Y., Kawano S., et al. The F(ab')2 fragment of an anti-ICAM-1 monoclonal antibody attenuates liver injury after orthotopic liver transplantation. Transplantation. 1996;61:99-104.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Greenwood J., Amos CL, Walters CE, et al. Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration. J Immunol. 2003;171:2099-2108.[Abstract/Free Full Text]
  • Isozaki H., Fujji K., Normura E., Hara H., et al. Calcium concentration in hepatocytes during liver ischaemiareperfusion injury and the effects of diltiazem and citrate on reperfused rat liver. Eur J Gastroenterol Hepatol. 2000;12:291-297.[Web of Science][Medline] [Order article via Infotrieve]
  • Chan PH Mitochondrial dysfunction and oxidative stress as determinants of cell death/survival in stroke. Ann NY Acad Sci. 2005;1042:203-209.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Schild L., Plumeyer F., Reiser G. Ca2+ rise within a narrow window of concentration prevents functional injury of mitochondria exposed to hypoxia/reoxygenation by increasing antioxidative defence. FEBS J. 2005;272: 5844-5852.[CrossRef][Medline] [Order article via Infotrieve]
  • Halestrap AP Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Transact. 2006;34:232-237.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Leducq N., Delams-Beauvieux MC, Mourderl-Marchasson I., et al. Mitochondrial and energetic dysfunctions of the liver during normothermic reperfusion: protective effect of cyclosporine and role of mitochondrial permeability transition pore. Transplant Proc. 2000;32:479-480.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Leducq N., Delams-Beauvieux MC, Mourdel-Marchasson I., et al. Mitochondrial permeability transition during hypothermic to normothermic reperfusion in rat liver demonstrated by the protective effect of cyclosporin A. Biochem J. 2000;336:501-506.[Web of Science]
  • Rolfe BE, Worth NR, World CJ, Campbell JH, Campbell GR Rho and vascular disease. Atherosclerosis. 2005;183: 1-16.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hall A. Rho GTPases and the actin cytoskeleton. Science. 1998; 279:509-514.[Abstract/Free Full Text]
  • Aepfelbacher M., Essler M., Huber E., Sagai M., Weber PC Bacterial toxins block endothelial wound repair: evidence that Rho GTPases control cytoskeletal rearrangements in migrating endothelial cells. Arterioscler Thromb Vasc Biol. 1997;17:1623-1629.[Abstract/Free Full Text]
  • van Watering S., van der Berk N., van Buul JD, et al. VCAM-1-mediated Rac signalling controls endothelial cell-cell contacts and leukocyte transmigration. Am J Physiol Cell Physiol. 2003;285:343-352.
  • Bokoch GM, Diebold BA Current molecular models of NADPH oxidase regulation by Rac GTPase. Blood. 2002;100:2692-2696.[Abstract/Free Full Text]
  • Mach F., Schonbeck U., Sukhova GK, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA. 1997;94:1931-1936.[Abstract/Free Full Text]
  • Lee W-J., Sheu WH, Chen YT, et al. Circulating CD40 ligand is elevated only in patients with more advanced symptomatic peripheral arterial diseases. Thrombosis Res. 2006;118:619-626.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ishikawa M., Vominkel T., Stokes KY, et al. CD40/CD40 ligand signalling in mouse cerebral microvasculature after focal ischemia/reperfusion. Circulation. 2005;111: 1690-1696.[Abstract/Free Full Text]
  • Ruggeri ZM Platelets in atherothrombosis. Nat Med. 2002;8:1227-1234.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Vilcek J. Basic cytokine biology. In: Thomson AW, Lotze MT, eds. The Cytokine Handbook. Vol 1. 4th ed. London, UK: Elsevier Science Academic Press; 2003:3-18.
  • Seekamp A., Till GO, Mulligan MS, et al. Role for selectins in local and remote tissue injury following ischemia and reperfusion. Am J Pathol. 1994;144:592-598.[Abstract]
  • Seekamp A., Warren JS, Mulligan MS, et al. Requirements for tumor necrosis factor-{alpha} and interleukin-1 in limb ischemia-reperfusion injury and associated lung injury. Am J Pathol. 1993;143:453-463.[Abstract]
  • Wang H., Czura CJ, Tracey KJ, et al. Tumor necrosis factor. In: Thomson AW, Lotze MT, eds. The Cytokine Handbook. Vol 22. 4th ed. London, UK: Elsevier Science Academic Press; 2003:837-860.
  • Sato N., Goto T., Satomi N., et al. Actions of tumor necrosis factor on cultured vascular endothelial cells: morphogenic modulation, growth inhibition, and cytotoxicity. J Natl Cancer Inst. 1986;76:1113-1121.[Web of Science][Medline] [Order article via Infotrieve]
  • van der Poll T., Lowry SF Tumor necrosis factor in sepsis: mediator of multiple organ failure or essential part of host defence? Shock. 1995;3:1-12.[Medline] [Order article via Infotrieve]
  • Kunkel SL, Remick DG, Strieter RM, Larrick JW Mechanisms that regulate the production and effects of tumour necrosis factor-{alpha}. Crit Rev Immunol. 1989; 9: 93-117.[Web of Science][Medline] [Order article via Infotrieve]
  • Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today. 1990;11: 97-101.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Pober JS, Lapierre LA, Stolpen AH, et al. Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumour necrosis factor and interleukin-1 species. J Immunol. 1987;138:3319-3324.[Abstract]
  • Isoda K., Shiigai M., Ishigami N., et al. Deficiency of interleukin-1 receptor antagonist promotes neointimal formation after injury. Circulation. 2003;108:516-518.[Abstract/Free Full Text]
  • Jiyang Y., Genant HK, Watt I., et al. A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radio-logic progression and correlation of Genant and Larsen scores. Arthritis Rheum. 2000;43:1001-1009.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kishimoto T. The biology of interleukin-6. Blood. 1989;74:1-10.[Free Full Text]
  • Tzoulaki I., Lee AJ, Rumley A., et al. C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study. Circulation. 2005;112:976-983.[Abstract/Free Full Text]
  • Castell JV, Gomez-Lechon, David M., et al. Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett. 1988;232:347-350.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Araki M., Fahmy N., Zhou L., et al. Expression of IL-8 during reperfusion of renal allografts is dependent on ischemic time. Transplantation. 2006;81:783-788.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Albadawi H., Patton GM, Kadowaki H., et al. Expression of IL-8 mRNA in human microvascular endothelium during experimental ischemia and reperfusion. Surg Forum. 2001;71:346-349.
  • Tua HT, Al-Badawi H., Stoner MC, et al. CXC chemokine expression and synthesis in skeletal muscle during ischemia/reperfusion. J Vasc Surg. 2005;42:337-343.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Engler RL, Dahlgren MD, Morris DD, et al. Role of cytokines in response to acute myocardial ischemia and reflow in dogs. Am J Physiol. 1986;251:314-323.
  • Li C., Jackson RM Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol. 2002;282:227-241.
  • Walmsley SR, Print C., Farahi N., et al. Hypoxia-induced neutrophil survival is mediated by HIF-1{alpha}-dependent NF-{kappa}B activity. J Exp Med. 2005;201:105-115.[Abstract/Free Full Text]
  • Karhausen J., Hasse VH, Colgan SP Inflammatory hypoxia: role of hypoxia-inducible factor. Cell Cycle. 2005;4:256-258.[Web of Science][Medline] [Order article via Infotrieve]
  • Keitzman T., Gorlach A. Reactive oxygen species in the control of hypoxia-inducible factor-mediated gene expression. Semin Cell Dev Biol. 2005;16:474-486.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Badwey JA, Karnovsky ML Active oxygen species and the function of phagocytic leukocytes. Annu Rev Biochem. 1980;49:695-726.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Salvemini D., Cuzzocrea S. Therapeutic potential of superoxide dismutase mimetics as therapeutic agents in critical care medicine. Crit Care Med. 2003;31:29-38.[CrossRef]
  • Meneshian A., Bulkley GB The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction. Microcirculation. 2002;9:161-175.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Flynn WJ Jr, Hoover EL Allopurinol plus standard resuscitation preserves hepatic blood flow and function following hemorrhagic shock. J Trauma. 1994;37:956-961.[Web of Science][Medline] [Order article via Infotrieve]
  • Soccio M., Toniato E., Evangelista V., Carluccio M., De Caterina R. Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants. Eur J Clin Invest. 2005;35:305-314.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cai H. NAD(P)H oxidase-dependent self-propagation of hydrogen peroxide and vascular disease. Circ Res. 2005;96:818-822.[Abstract/Free Full Text]
  • Wyche KE, Wang SS, Griendling KK, et al. C242T CYBA polymorphism of the NADPH oxidase is associated with reduced respiratory burst in human neutrophils. Hypertension. 2004;43:1246-1251.[Abstract/Free Full Text]
  • Satoh M., Fujimato S., Haruna Y., et al. NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy. Am J Physiol Renal Physiol. 2005;288:1144-1152.[CrossRef]
  • Krotz F., Sohn HY, Gloe T., et al. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood. 2002;100:917-924.[Abstract/Free Full Text]
  • Darley-Usmar V., Wiseman H., Halliwell B. Nitric oxide and oxygen radicals: a question of balance. FEBS Lett. 1995;369:131-135.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • McLeod LL, Alayash AI Detection of a ferrylhemoglobin intermediate in an endothelial cell model after hypoxiareoxygenation. Am J Physiol. 1999;277(1, Pt 2):92-99.
  • Li C., Jackson RM Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol. 2002;282:227-241.
  • Bladier C., Wolvetang EJ, Hutchinson P., et al. Response of a primary human fibroblast cell line to H2O2: sequence-like growth arrest or apoptosis? Cell Growth Differ. 1997;8:589-598.[Abstract]
  • Hoshino S., Kikuchi Y., Nakajima M., et al. Endothelial NO Synthase (eNOS) phosphorylation regulates coronary diameter during ischemia-reperfusion in association with oxidative stress. Free Radic Res. 2005;39:481-489.[Web of Science][Medline] [Order article via Infotrieve]
  • Kramer JH, Misic V., Weglicki WB Lipid peroxidation-derived free radical production and postischemic myocardial reperfusion injury. Ann NY Acad Sci. 1994; 723:180-196.[Web of Science][Medline] [Order article via Infotrieve]
  • van der Karaij AM, Schoondervoerd K., Koester FJ, et al. Lipid peroxidation and its significance for (post) ischemic cardiovascular injury. Prog Clin Biol Res. 1989;301:61-72.[Medline] [Order article via Infotrieve]
  • Erdogan H., Fadillioglu E., Yagmurca M., et al. Protein oxidation and lipid peroxidation after renal ischemiareperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res. 2006;34:41-46.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tam BB, Siu AW, Lee EY Effects of vitamin E and pinoline on retinal lipid peroxidation. Clin Exp Optom. 2004;87:171-174.[Medline] [Order article via Infotrieve]
  • Nezu K., Kushibe K., Tojo T., et al. Protection against lipid peroxidation induced during preservation of lungs for transplantation. J Heart Lung Transplant. 1994;13:998-1002.[Web of Science][Medline] [Order article via Infotrieve]
  • Holvoet P. Endothelial dysfunction, oxidation of low-density lipoprotein, and cardiovascular disease. Ther Apher. 1999;3:287-293.[CrossRef][Medline] [Order article via Infotrieve]
  • Muralikrishna Adibatla A, Hatcher JF Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med. 2006; 40:376-387.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gupta S., Agarwal A., Sharma RK The role of placental oxidation stress and lipid peroxidation in preeclampsia. Obstet Gynecol Surv. 2005;60: 807-816.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Byrne AT, Johnson AH Lipid peroxidation. In: Grace PA, Mathie RT, eds. Ischaemia-Reperfusion Injury. Oxford, UK: Blackwell Science; 1999:148-156.
  • Del Rio D., Stewart AJ, Pellegrini N. Review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis. 2005;15:316-328.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Halliwell B., Gutteridge Jmc. Free Radicals in Biology and Medicine. 3rd ed. Oxford, UK: Oxford University Press; 1999.
  • Gutteridge Jmc, Mitchell J. Redox imbalance in the critically ill. Br Med Bull. 1999;55:49-75.[Abstract/Free Full Text]
  • Bertuglia S., Giusti A. Microvascular oxygenation, oxidative stress, NO suppression and superoxide dismutase during postischemic reperfusion. Am J Physiol Heart Circ Physiol. 2003;285:1064-1071.
  • Flaherty JT, Pitt B., Gruber JW, et al. Recombinant human superoxide dismutase (h-SOD) fails to improve recovery of ventricular function in patients undergoing coronary angioplasty for acute myocardial infarction. Circulation. 1994;89:1982-1991.[Abstract/Free Full Text]
  • Young B., Runge JW, Waxman KS, et al. Effects of pegorgotein on neurological outcome of patients with severe head injury: a multicenter, randomised controlled trial. JAMA. 1996;276:538-543.[Abstract/Free Full Text]
  • Paterson IS, Klausner JM, Goldman G., et al. Pulmonary edema after aneurysm surgery is modified by mannitol. Ann Surg. 1989;210:796-801.[Web of Science][Medline] [Order article via Infotrieve]
  • Vallance P., Collier J. Biology and clinical relevance of nitric oxide. Br Med J. 1994;309:453-457.[Free Full Text]
  • Forstermann U., Munzel T. Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation. 2006;113:1708-1714.[Abstract/Free Full Text]
  • Channon KM Tetrahydrobiopterin: regulator of endothelial nitric oxide synthase in vascular disease. Trends Cardiovasc Med. 2004;14:323-327.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Khanna A., Cowled PA, Fitridge RA Nitric oxide and skeletal muscle reperfusion injury: current controversies. J Surg Res. 2005;128:98-107.[Web of Science][Medline] [Order article via Infotrieve]
  • Virag L., Szobo E., Gergely P. Peroxynitrite-induced cytotoxicity: mechanism and opportunities for intervention. Toxicol Lett. 2003;140-141:113-124.[CrossRef]
  • Tiefenbacher CP Tetrahydrobiopterin: a critical cofactor for eNOS and a strategy in the treatment of endothelial dysfunction? Am J Physiol Heart Circ Physiol. 2001;280:2484-2488.
  • Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987;327: 524-526.[CrossRef][Medline] [Order article via Infotrieve]
  • Lee YH, Wei FC, Lee J., et al. Effect of postischemic reperfusion on microcirculation and lipid metabolism of skeletal muscle. Microsurgery. 1995;16:522-527.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hein TW, Zhang C., Wang W., et al. Ischemia-reperfusion selectively impairs nitric oxide-mediated dilation in coronary arteries: counteracting role of arginase. FASEB J. 2003:17:2328-2330.[Abstract/Free Full Text]
  • DeFily DV Control of microvascular resistance in physiological conditions and reperfusion. J Mol Cell Cardiol. 1998;30:2547-2554.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Santiago-Delpin EA The endothelium and early immune activation: new perspective and interactions. Transplant Proc. 2004;36:1709-1713.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Böhm F., Setergren M., Gonon AT, et al. The endothelin-1 receptor antagonist bosentan protects against ischaemia/reperfusion-induced endothelial dysfunction in humans. Clin Sci. 2005;108:357-363.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tsui Jcs, Dashwood MR A Role for endothelin-1 in peripheral vascular disease. Curr Vasc Pharmacol. 2005;3:325-332.[CrossRef][Medline] [Order article via Infotrieve]
  • Menger MD, Steiner D., Messmer K. Microvascular ischemia-reperfusion injury in striated muscle: significance of "no reflow." Am J Physiol. 1992;263(6,Pt2): H1892-H1900.[Web of Science][Medline] [Order article via Infotrieve]
  • Hardy SC, Homer-Vanniasinkam S., Gough MJ The triphasic pattern skeletal muscle blood flow in reperfusion injury: an experimental model with implications for surgery on the acutely ischaemic lower limb. Eur J Vasc Surg. 1990;4:587-590.[CrossRef][Medline] [Order article via Infotrieve]
  • Mazzoni MC, Borgstrom P., Warnke KC, et al. Mechanisms and implications of capillary endothelial swelling and luminal narrowing in low-flow ischemias. Int J Microcirc Clin Exp. 1995;15:265-270.[Web of Science][Medline] [Order article via Infotrieve]
  • Harris AG, Steinbauer M., Leiderer R., et al. Role of leukocyte plugging and edema in skeletal muscle ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 1997;273:989-996.
  • Ng Chs, Wan S., Yin AP, et al. Pulmonary dysfunction after cardiac surgery. Chest. 2002;121:1269-1277.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Levi M., van der Poll. Two-way interactions between inflammation and coagulation. Trends Cardiovasc Med. 2005;15:254-259.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kumar KP, Homer-Vanniasinkam S., Lim YC, et al. Neutrophil integrin expression and interlukin 8 secretion in lower limb ischaemia-reperfusion. Br J Surg. 1995;82:1563.
  • Schutte H., Witzenrath M., Mayer K., et al. Short-term "pre-conditioning" with inhailed nitric oxide protects rabbit lungs against ischemia-reperfusion injury. Transplantation. 2001;72:1363-1370.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Schutte H., Lockinger A., Seeger W., et al. Aerosolized PGE1, PGE2 and nitroprusside protect against vascular leakage in lung ischaemia-reperfusion. Eur Respir J. 2001;18:15-22.[Abstract/Free Full Text]
  • Nanobashvili J., Newmayer C., Fuegl A., et al. Development of "no-reflow" phenomenon in ischemia/ reperfusion injury: failure of active vasomotility and not simply passive vasoconstriction. Eur Surg Res. 2003; 35:417-424.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • von Dobschuetz E., Bleiziffer O., Pahernik S., et al. Soluble complement receptor 1 preserves endothelial barrier function and microcirculation in postischemic pancreatitis in rat. Am J Physiol Gastrointest Liver Physiol. 2004; 286:791-796.[CrossRef]
  • Zimmerman BJ, Granger DN Reperfusion Injury. Surg Clin North Am. 1992;72:65-83.[Web of Science][Medline] [Order article via Infotrieve]
  • Forman MB, Puett DW, Virmani R. Endothelial and myocardial injury during ischemia and reperfusion: pathogenesis and therapeutic implications. J Am Coll Cardiol. 1989;13:450-459.[Abstract]
  • Sobido F., Millajo VJ, Hobson RW II, et al. Skeletal muscle ischemia-reperfusion injury: a review of endothelial cell-leukocyte interactions. J Invest Surg. 1994;7:39-47.[Medline] [Order article via Infotrieve]
  • Lynman E., Sklar LA, Taylor AD, et al. ß2-integrins mediate stable adhesion in collisional interactions between neutrophils and ICAM-1-expressing cells. J Leukoc Biol. 1998;64:622-630.[Abstract]
  • Ritter LS, McDonagh PF Low-flow reperfusion after myocardial ischemia enhances leukocyte accumulation in coronary microcirculation. Am J Physiol Heart Circ Physiol. 1997;273:1154-1165.
  • Cooper D., Russell J., Chitman KD, et al. Leukocyte dependence of platelet adhesion in postcapillary venules. Am J Physiol Heart Circ Physiol. 2004;286:1895-1900.[CrossRef]
  • Omari KM, Dorovini-Zis K. CD40 expressed by human brain endothelial cells regulates CD40+ T cell adhesion to endothelium. J Neuroimmunol. 2003;134:166-178.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Monaco C., Andreakos E., Young S., Feldmann M., Paleolog E. Cell-mediated signalling to vascular endothelium: induction of cytokines, chemokines, and tissue factor. J Leukoc Biol. 2002;71:659-668.[Abstract/Free Full Text]
  • Henn V., Slupsky JR, Grafe M., et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature. 1998;391:591-594.[CrossRef][Medline] [Order article via Infotrieve]
  • Kurose I., Anderson DC, Grafe M., et al. Molecular determinants of reperfusion-induced leukocyte adhesion and vascular protein leakage. Circ Res. 1994;74: 336-343.[Abstract/Free Full Text]
  • Murray CJ, Jennings RB, Reimer KA Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1015-1022.
  • Jenkins DP, Baxter GF, Yellon DM The pathophysiology of ischemic preconditioning. Pharmacol Res. 1995;31:219-224.[Web of Science][Medline] [Order article via Infotrieve]
  • Pasupathy S., Homer-Vanniasinkam S. Ischaemic preconditioning protects against ischaemia/reperfusion injury: emerging concepts. Eur J Vasc Endovasc Surg. 2005;29:106-115.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kuzuya T., Hoshida S., Yamashita N., et al. Delayed effects of sublethal ischemia on acquisition of tolerance to ischemia. Circ Res. 1993;72:1293-1299.[Abstract/Free Full Text]
  • Crisostomo PR, Wairiuko GM, Wang M., et al. Preconditioning versus postconditioning: mechanisms and therapeutic potentials. J Am Coll Surg. 2006;202: 797-812.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Garlid KD, Dos SP, Xie ZJ, et al. Mitochondrial potassium transport: the role of mitochondrial ATP-sensitive K(+) channel in cardiac function and cardioprotection. Biochim Biophys Acta. 2003;1606:1-21.[Medline] [Order article via Infotrieve]
  • Sato T., Sasaki N., O'Rourke B., et al. Nicorandil, a potent cardioprotective agent acts by opening mitochondrial ATP-dependent potassium channels. J Am Coll Cardiol. 2000;35:514-518.[Abstract/Free Full Text]
  • Sato T., Sasaki N., Seharaseyon J., et al. Selective pharmacological agents implicate mitochondrial but not sarcolemmal K(ATP) channels in ischemic cardioprotection. Circulation. 2000;101:2418-2423.[Abstract/Free Full Text]
  • Stenzel-Poore MP, Stevens SL, Xiong Z., et al. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet. 2003;362:1028-1037.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jennings RB, Sebbag L., Schwartz LM, et al. Metabolism of preconditioned myocardium: effect of loss and reinstatement of cardioprotection. J Mol Cell Cardiol. 2001;33:1571-1588.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Papanastasious S., Estdale SE, Homer-Vanniasinkam S., et al. Protective effect of preconditioning and adenosine pre-treatment in experimental skeletal muscle reperfusion injury. Br J Surg. 1999;86:916-922.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Peralta C., Closa D., Hotter G., et al. Liver ischemic preconditioning is mediated by inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun. 1996;229:264-270.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Akimitsu T., Gute DC, Korthuis RJ, et al. Ischemic preconditioning attenuates postischemic leukocyte adhesion and emigration. Am J Physiol. 1996;271(5,Pt2):2052-2059.
  • Alkhulaifi AM, Yellon DM, Pugsley WB Preconditioning the human heart during aorto-coronary bypass surgery. Eur J Cardiothorac Surg. 1994;8: 270-275.[Abstract]
  • Wu ZK, Livainen T., Pehkonen E., et al. Ischemic preconditioning suppresses ventricular tachyarrhythmias after myocardial revascularisation. Circulation. 2002; 106:3091-3096.[Abstract/Free Full Text]
  • Wu ZK, Livainen T., Pehkonen E., et al. Arrhythmias in off-pump coronary artery bypass grafting and the antiarrhythmic effect of regional ischemic preconditioning. J Cardiothorac Vasc Anaesth. 2003;17:459-464.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Wu ZK, Livainen T., Pehkonen E., et al. Perioperative and postoperative arrhythmia in three-vessel coronary artery disease patients and antiarrhythmic effects of ischemic preconditioning. Eur J Cardiothorac Surg. 2003;23:578-584.[Abstract/Free Full Text]
  • Mortimer SL, Kodl CT, Reiling CR, et al. Preconditioning-induced reduction of purine metabolite accumulation during ischemia: memory and multiple cycles. Basic Res Cardiol. 2000;95:119-126.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Sandhu R., Dias RJ, Mao GD, et al. Ischemic preconditioning: differences in protection and susceptibility to blockade with single-cycle versus multicycle transient ischemia. Circulation. 1997;96:984-995.[Abstract/Free Full Text]
  • Pitcher JM, Wang M., Tsai BM, et al. Preconditioning: gender effects. J Surg Res. 2005;129:202-220.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Pitcher JM, Nagy RD, Tsai BM, et al. Is the preconditioning threshold different in females? J Surg Res. 2005;125:168-172.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Chen S., Li G., Long L. Clinical research of ischemic preconditioning on lung protection. Hunan Yi Ke da Xue Xue Bao. 1999;24:357-359.[Medline] [Order article via Infotrieve]
  • Clavien PA, Yadav S., Sindram D., et al. Protective effects of ischaemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg. 2000;232:155-162.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Cross GJ Prologue, pharmacological preconditioning: potential new treatment modalities for ischaemic myocardium. Vasc Pharmacol. 2005;42:199.[CrossRef]
  • Critz SD, Cohen MV, Downey JM Mechanisms of acetylcholine- and bradykinin-induced preconditioning. Vascul Pharmacol. 2005;42:201-209.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of the myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285: 579-588.
  • Staat P., Rioufol G., Piot C., et al. Postconditioning the human heart. Circulation. 2005;112:2143-2148.[Abstract/Free Full Text]
  • Yang XM, Proctor JB, Cui L., et al. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signal pathways. J Am Coll Cardiol. 2004;44:1103-1110.[Abstract/Free Full Text]
  • Philipp S., Downey JM, Cohen MV Postconditioning must be initiated in less than 1 minute following reperfusion and is dependent on adenosine receptors and P13-kinase. Circulation. 2004;110(suppl 3):804.

Vascular and Endovascular Surgery, Vol. 41, No. 4, 277-293 (2007)
DOI: 10.1177/1538574407304510
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Eur. J. Cardiothorac. Surg.Home page
G. Valen
Extracardiac approaches to protecting the heart
Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 651 - 657.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hardev Ramandeep Singh Girn
Right arrow Articles by Homer-Vanniasinkam, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hardev Ramandeep Singh Girn,
Right arrow Articles by Homer-Vanniasinkam, S.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Advertisement